MINERVA MEDICA is a renowned academic journal published by EDIZIONI MINERVA MEDICA, located in Turin, Italy. Established in 1945, it has positioned itself as a significant contributor to the field of medicine, particularly in the miscellaneous medicine category, as evidenced by its Q3 ranking according to the 2023 category quartiles. The journal is indexed under the ISSN 0026-4806 and E-ISSN 1827-1669, ensuring wide accessibility and dissemination of knowledge among medical professionals, researchers, and students alike. With a robust Scopus ranking of #64 out of 636 in General Medicine, placing it in the 90th percentile, MINERVA MEDICA serves as a vital resource for those seeking to stay updated on contemporary medical research and advancements. While not an open-access journal, its commitment to quality and relevance in the medical landscape makes it an essential read for anyone involved in the healthcare sector.

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

Clinical and Investigative Medicine is a prestigious journal dedicated to advancing the fields of clinical research and medical practice, published by the Canadian Society for Clinical Investigation. With a history of insightful contributions since its inception in 1978, the journal serves as a vital platform for researchers, clinicians, and healthcare professionals to disseminate innovative findings and explore critical issues facing contemporary medicine. Housed within the Q3 quartile of the Medicine category, it boasts an impressive Scopus ranking of #280/636, placing it within the 56th percentile amongst its peers. Although it operates on a subscription basis, the journal remains accessible to a broad audience interested in comprehensive reviews, original research, and cutting-edge methodology, ensuring that vital information reaches a global readership. Submit your research to Clinical and Investigative Medicine and contribute to the ongoing dialogue that shapes the future of patient care and medical innovation.

The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.

Therapeutic Advances in Chronic Disease is a distinguished open-access journal published by SAGE Publications Ltd, with a focus on innovative research and clinical practices addressing chronic diseases—a field increasingly relevant in today's healthcare landscape. Since its inception in 2010, the journal has committed itself to disseminating high-quality research that informs both theory and practice. With an impressive impact factor and ranked Q1 in Medicine (miscellaneous) in 2023, this journal boasts recognition as one of the top-tier publications in the medical community, placing it in the 79th percentile among its peers. Accessible since 2019, it aims to bridge the gap between cutting-edge research and its application in improving patient outcomes, inviting contributions from researchers, clinicians, and health professionals. The journal's comprehensive scope encompasses various aspects of chronic disease management, making it an invaluable resource for those seeking to advance their understanding of this critical field.

YONAGO ACTA MEDICA, published by Tottori University Medical Press, is a prominent journal in the field of Medicine, recognized for its contributions and academic rigor since its inception in 1965. With an ISSN of 0513-5710 and E-ISSN of 1346-8049, this journal is situated in Japan and spans significant periods of convergence from 1965 to 1977 and from 1986 to 2024. Classified within the Q3 category of Medicine (Miscellaneous) and holding a respectable Scopus rank of 275 out of 636 in General Medicine, YONAGO ACTA MEDICA offers an invaluable platform for researchers, professionals, and students to disseminate innovative studies and findings in diverse medical topics. While the journal currently does not operate under an open-access model, it remains committed to promoting academic excellence and advancing medical knowledge through peer-reviewed publications. Address inquiries and contributions to 86 NISHI-CHO, YONAGO, TOTTORI-KEN 683-8503, JAPAN.

Canadian Journal of Pain-Revue Canadienne de la Douleur is a premier, open-access journal published by Taylor & Francis Ltd, focusing on critical advancements in the field of pain management and anesthesiology. Since its inception as an open-access outlet in 2017, this journal has made significant strides in disseminating high-quality research and clinical findings, catering to a diverse audience of researchers, healthcare professionals, and students. With an impressive Q2 ranking in the fields of Anesthesiology and Pain Medicine, and a robust Scopus rank of 48 out of 136, the journal plays a vital role in enhancing knowledge, sharing innovative treatment modalities, and influencing best practices in pain alleviation. The journal’s commitment to accessibility has further solidified its position as a crucial resource in pain research, inviting contributions that aim to address the multifaceted challenges associated with pain management globally. Readers can find a wealth of invaluable peer-reviewed articles, reviews, and commentaries that support continued learning and collaboration within the field.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, published by Elsevier Taiwan, stands as a significant academic resource in the field of medical research, particularly within the miscellaneous categories of medicine. With an impressive impact factor and categorized within the Q2 tier of medical journals, it boasts a commendable position in Scopus rankings—#63 out of 636 in General Medicine, placing it in the 90th percentile. Established initially in 1961 and evolving through its open access format since 2016, this journal fosters the dissemination of innovative research, serving an important role in the global medical community. Located in Taipei, Taiwan, it particularly emphasizes studies relevant to the Taiwanese population while welcoming international contributions, enhancing both local and global health discourse. As a trusted platform for researchers, professionals, and students alike, the journal aims to propel advancements in medical science and practice through high-quality peer-reviewed articles. ISSN: 0929-6646, E-ISSN: 1876-0821.

Universitas Medica is a prominent journal dedicated to advancing the field of medical sciences, published by the Pontificia Universidad Javeriana, Facultad de Medicina. Since its transition to an Open Access format in 2010, it has played a pivotal role in promoting the dissemination of high-quality medical research. Featuring a diverse array of studies encompassing clinical practice, public health, and medical education, Universitas Medica aims to provide researchers, healthcare professionals, and students with invaluable insights and the latest findings in medicine. With a focus on enhancing accessibility and fostering collaboration across the medical community, this journal stands out as a critical resource for those looking to stay abreast of innovations and trends. The journal is indexed under ISSN 0041-9095 and E-ISSN 2011-0839 and operates from its base in Bogotá, Colombia, contributing significantly to the scientific landscape both regionally and internationally.

PANMINERVA MEDICA is a distinguished journal published by EDIZIONI MINERVA MEDICA, focusing on the multifaceted field of medicine since its inception in 1959. With an ISSN of 0031-0808 and an E-ISSN of 1827-1898, this journal is esteemed for its rigorous peer-review process and its contribution to clinical and experimental research across various domains of medicine. Based in Italy, it holds a commendable position in the 2023 Scopus rankings, where it is placed in the 84th percentile among general medicine journals, highlighting its relevance and scholarly impact. As a Q3 category journal in the medicine (miscellaneous) quartiles, PANMINERVA MEDICA is committed to disseminating high-quality research, fostering scientific dialogue, and advancing medical knowledge globally. While currently not offering open access, it serves as a vital resource for researchers, practitioners, and students seeking to stay at the forefront of medical advancements. The journal is poised to continue its tradition of excellence as it converges into 2024, ensuring robust discourse in healthcare and clinical practices.